Clinical Trial Update: Bupropion for the Treatment of Apathy in Alzheimer's Dementia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating bupropion for treating apathy in Alzheimer's dementia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• bupropion (bupropion)

Snippet

Sponsor: University Hospital, Bonn | Conditions: Apathy in Dementia | Phase 3 | Status: COMPLETED